z-logo
open-access-imgOpen Access
Persistence of Infectious HIV on Follicular Dendritic Cells
Author(s) -
Beverly A. Smith,
Suzanne Gartner,
Yiling Liu,
Alan S. Perelson,
Nikolaos I. Stilianakis,
Brandon F. Keele,
Thomas M. Kerkering,
Andrea FerreiraGonzalez,
Andras K. Szakal,
John G. Tew,
Gregory F. Burton
Publication year - 2001
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.166.1.690
Subject(s) - infectivity , virus , virology , biology , follicular dendritic cells , viral replication , in vivo , in vitro , human immunodeficiency virus (hiv) , persistence (discontinuity) , immunology , genetics , cytotoxic t cell , antigen presenting cell , geotechnical engineering , engineering
Follicular dendritic cells (FDCs) trap Ags and retain them in their native state for many months. Shortly after infection, HIV particles are trapped on FDCs and can be observed until the follicular network is destroyed. We sought to determine whether FDCs could maintain trapped virus in an infectious state for long periods of time. Because virus replication would replenish the HIV reservoir and thus falsely prolong recovery of infectious virus, we used a nonpermissive murine model to examine maintenance of HIV infectivity in vivo. We also examined human FDCs in vitro to determine whether they could maintain HIV infectivity. FDC-trapped virus remained infectious in vivo at all time points examined over a 9-mo period. Remarkably, as few as 100 FDCs were sufficient to transmit infection throughout the 9-mo period. Human FDCs maintained HIV infectivity for at least 25 days in vitro, whereas virus without FDCs lost infectivity after only a few days. These data indicate that HIV retained on FDCs can be long lived even in the absence of viral replication and suggest that FDCs stabilize and protect HIV, thus providing a long-term reservoir of infectious virus. These trapped stores of HIV may be replenished with replicating virus that persists even under highly active antiretroviral therapy and would likely be capable of causing infection on cessation of drug therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom